Liquefactive necrosis

From WikiMD's WELLNESSPEDIA

Liquefactive necrosis is a type of necrosis which results in a transformation of the tissue into a liquid viscous mass. Often it is associated with focal bacterial or fungal infections, and can also occur in response to ischemic injury such as a cerebrovascular accident.

Causes[edit]

Liquefactive necrosis is commonly caused by lack of oxygen (ischemia) and subsequent bacterial infection. It can also be caused by certain types of bacteria such as Staphylococcus, Streptococcus, and E. coli, as well as certain types of fungi.

Pathology[edit]

In liquefactive necrosis, the affected cell is completely digested by hydrolytic enzymes, resulting in a soft, circumscribed lesion consisting of pus and the remains of necrotic tissue. The dead cells are then rapidly destroyed, resulting in a soft, creamy yellow, necrotic area that is filled with pus.

Diagnosis[edit]

Diagnosis of liquefactive necrosis is typically made through a combination of clinical history, physical examination, and laboratory tests. Imaging studies such as MRI or CT scan may also be used to visualize the area of necrosis.

Treatment[edit]

Treatment for liquefactive necrosis typically involves addressing the underlying cause of the necrosis. This may include antibiotics to treat infection, or surgical intervention to remove the necrotic tissue.

See also[edit]

References[edit]



Sponsored Health Resource

W8MD weight loss success

W8MD Weight Loss, Sleep & MedSpa

Looking for physician-supervised weight loss, semaglutide, tirzepatide, or GLP-1 receptor agonist options? W8MD helps eligible patients in New York City, Brooklyn, New Jersey, Connecticut, Pennsylvania, Delaware, and greater Philadelphia with medical weight loss, sleep medicine, and long-term maintenance support.

GLP-1 specials: Affordable GLP-1 injections NYC and Philadelphia starting from $29.99/week and up for semaglutide with insurance accepted for qualifying visits, and $45/week and up for tirzepatide with insurance accepted for qualifying visits. Self-pay options start from $59.99/week and up for semaglutide and $69.99/week and up for tirzepatide.

Book a W8MD appointment · View GLP-1 specials

Paid promotional message. Eligibility, pricing, insurance coverage, medication availability, and results vary. Medical evaluation required.

Medical Disclaimer: WikiMD is for informational purposes only and is not a substitute for professional medical advice. Content may be inaccurate or outdated and should not be used for diagnosis or treatment. Always consult your healthcare provider for medical decisions. Verify information with trusted sources such as CDC.gov and NIH.gov. By using this site, you agree that WikiMD is not liable for any outcomes related to its content. See full disclaimer.

Credits:Most images are courtesy of Wikimedia commons, and templates, categories Wikipedia, licensed under CC BY SA or similar.